Dr. Kim's STEM CELL CLINIC

Doctors

Our Doctors

From your first consultation through recovery,
one specialist works with you to create a personalized plan just for you.

Dr. Hyun Soo Kim, Founder & Medical Director

Dr. Hyun Soo KimFounder & Medical Director

Founder & Medical Director, Dr. Kim's Stem Cell Clinic · CEO, Pharmicell Co., Ltd.

  • Professor of Hematology-Oncology, Ajou University · Adjunct Professor, Graduate School of Molecular Science and Technology

  • Adjunct Professor / Visiting Associate Professor, Yonsei University Wonju College of Medicine

  • Planning Committee member for stem cell commercialization, Ministry of Health and Welfare · Chief planning committee member, national inter-ministry stem cell research plan

  • Committee member for stem cells, Ultra Program, Ministry of Science and Technology

  • Finalist, 14th CNBC Asia Business Leaders Awards (ABLA), 2015

  • Graduate of Ajou University Graduate School of Medicine and Yonsei University Wonju College of Medicine

Signature of Dr. Hyun Soo Kim

Milestones in stem cell care and research

  • 1995

    Korea's first autologous peripheral blood stem cell transplant

  • 1997

    Developed a cancer immunotherapy protocol

  • 1999

    Korea's first mesenchymal stem cell transplant

  • 2000

    World's first patent for differentiating mesenchymal stem cells into neural cells (granted in 7 countries including the US and EU)

    Korea's first dendritic cell cancer immunotherapy supported by the Ministry of Health and Welfare

    Patent registered for dendritic cell differentiation in cancer immunotherapy (7 countries including the US and EU)

  • 2002

    Performed bone marrow transplants for some 300 patients

  • 2004

    Selected for and led a next-generation growth engine research project, Ministry of Health and Welfare (cerebral hemorrhage, Parkinson's disease, hemorrhagic brain disorders)

  • 2005

    Selected for and led a core technology development research project, Ministry of Commerce, Industry and Energy (dendritic cells for cancer immunotherapy)

Awards

Recognised in Korea and beyond —
the medical technology and research of Dr. Kim's Stem Cell Clinic

  • 2005 Health Industry Technology Awards

    Grand Prize, Research

    Minister of Health and Welfare

  • 2006 Korea Health Industry Awards

    Grand Prize, Industry Development

    Minister of Health and Welfare

  • Designation as an advanced regenerative medicine institution — Kim Hyun Soo Internal Medicine Clinic, designation no. Regen-1-0007, Minister of Health and Welfare (9 November 2023)
  • Ministerial commendation — Pharmicell Co., Ltd. CEO Kim Hyun Soo, no. 116454, for contributing to national industrial development by improving venture management and productivity, Minister of Trade, Industry and Energy (1 December 2016)
  • Innovative pharmaceutical company certificate — Pharmicell Co., Ltd., no. 2019-4, valid 1 July 2019 to 30 June 2022, Minister of Health and Welfare
  • Innovative pharmaceutical company certificate — Pharmicell, no. 2025-2, valid 1 July 2025 to 30 June 2028, Minister of Health and Welfare
  • Korean World-class Product Award 2007 — FCB-Pharmicell, stem cell therapy for acute myocardial infarction, no. 2007-330, Minister of Commerce, Industry and Energy (24 December 2007)
  • Technology-innovative small and medium enterprise (INNO-BIZ) certificate — FCB-Pharmicell Co., Ltd., representative Kim Hyun Soo, no. R6065-1706, grade A, valid 12 September 2009 to 11 September 2012, Administrator of the Small and Medium Business Administration
  • Letter of appointment — FCB-Pharmicell Co., Ltd. CEO Kim Hyun Soo, appointed a member of the Bio Industry Strategy Council for promoting the industrialisation of biotechnology, Minister of Commerce, Industry and Energy (17 October 2006)
  • Innovative pharmaceutical company certificate — Pharmicell, no. 2022-2, valid 1 July 2022 to 30 June 2025, Minister of Health and Welfare
Dr. Hyeong Chang Kang, Director

Dr. Hyeong Chang KangDirector

Director, Dr. Kim's Stem Cell Clinic · Head of R&D Center, Pharmicell Co., Ltd.

  • Full member, Korean Association of Internal Medicine

  • Internal medicine residency, Seoul National University Hospital

  • Graduate of Seoul National University School of Medicine

  • Graduate of Seoul National University College of Engineering

Signature of Dr. Hyeong Chang Kang